3/13/14 Thurs. am Pfizer Loses Celebrex Patent Extension Case

http://www.dowjonesmonitor.com/

Post No. 2,597The following is brought to you by Intellivest Securities Research, Inc. Toward the end of this Blog is a list of the Dow 30 current CEOs, and a recent ranking of the Dow 30 components by market capitalization  and a summary of Dow 30 components'  recent SEC filings.

A  read of the print editions of  Thursday's Wall St. Journal,  Financial Times,  Investor's Business Daily,  New York Times, USA Today, Atlanta Journal & Constitution and Daily Report (Ga. - carries Bloomberg)    yielded the following stories about Dow Jones Industrial Average 30 component companies and the Dow with stories about the Dow aggregated first and then items about Dow Jones Industrial Average 30 companies presented alphabetically, followed by a separate table of Dow component's symbol and Wednesday's closing   stock prices and related data in alphabetical order.

The Dow Jones Industrial Average: The Dow Jones Industrial Average closed Wednesday at 16340.08 down 11.17 or 0.07%    from Tuesday's close of 16351.25. For the year the Dow is down 1.43 %. Of the Dow components  15   gained and 15 declined.  The biggest gainer dollar-wise    and percentage-wise was Chevron up $1.1or 1%.   The biggest decliner dollar-wise  was Boeing down $1.14 and percentage-wise was Pfizer down 1.36%.

Wednesday's Dow Jones Industrial Average closing numerator was 2544.41 down  1.74 from  Tuesday's closing numerator of 2546.15. This is the sum of all 30 closing prices. A short cut to the Dow numerator is to multiply the closing Dow by the Divisor. Now, if you divide the Dow numerator change for today by the divisor (0.15571590501117) you get the change in today's Dow. A dollar increase or decrease in a Dow stock results in a $6.42 change in the Dow Index.

WSJ pC4 "Worries unsettle stocks" by Alexandra Scaggs says the S&P edged higher as investors weighed worries about global growth vs. recent signs of stability in the US economy.

IBD pB2 "Indexes reverse higher as Nasdaq leads are bound" by Vincent Mao says stocks bounced back from an early selloff to end higher Wed as stocks had lower vol and the current outlook is a confirmed uptrend.

FT p21 "Rite Aid advances as Goldman forecasts improved sales growth" by Eric Platt says overall US equity markets drifted lower.  Goldman Sachs research lifted its rating on Rite Aid to buy.


As of the open of the market on Thursday the current divisor for the Dow Jones Industrial Average found at page C5 of Thursday's Wall St. Journal is 0.15571590501117. Thursday's trailing P/E ratio is 16.05 down from Wednesday's trailing P/E ratio of 16.07      (last year it was 15.94).  Thursday's P/E estimate is 14.75 unchanged from  Wednesday's P/E estimate of 14.75   (year ago it was 12.69) and Thursday's dividend yield is 2.19 up  from Tuesday's dividend yield of 2.17  (last year it was 2.45). The Dow's all-time high was 16,576.66 on December 31, 2013. The 12 year low close for the Dow was on March 9, 2009 when it fell to 6,547.05.


The average closing price (the closing numerator divided by 30) of  Wednesday's Dow Jones Industrial Average was $84.81 down 6 cents    from Tuesday's average closing price of $84.87. The median closing price of   Wednesday's Dow Jones Industrial Average was $81.38 (PG/DIS) up $1.38 cents  from Tuesday's median closing price of $80.00    (PG/DIS). The lowest volume was Travelers and the highest volume was Verizon  .

If Wednesday morning before the market opened you had purchased 100 shares of each of the Dow Jones Industrial Average 30 shares (assuming you could buy fractional shares and assuming no transaction costs or dividends) and sold at the close you would have lost $174  ($254,615 - $254,441).

3/12/14 Wed. 4:11   pm MarketWatch by Victor Reklaitis says U.S. stocks finished little changed on Wednesday, erasing early losses that followed a sell-off in Asian and European equities. Analysts attributed the early selling to worries about China's slowdown and continued Russia-Ukraine tensions. The S&P 500 SPX +0.03% ended up 0.57 point, or less than 0.1%, at 1,868.20, leaving the benchmark index just 0.5% off Friday's record close. The Dow Jones Industrial Average DJIA -0.07% dipped 11.24 points, or 0.1%, to close at 16,340.01, dropping for the third day in a row. The Nasdaq Composite COMP +0.38% gained 16.14 points, or 0.4%, to finish at 4,323.33, halting a four-session losing streak. There was a lack of catalysts on Wednesday, said Peter Cardillo, chief market economist at Rockwell Global Capital. "Basically, we have no economic numbers to speak of today," Cardillo told MarketWatch. The market just followed the international markets in the early going, but it didn't show signs of collapsing and stayed near its record highs, he said.

Thursday's Dow News followed by Wednesday's Closing Dow Numbers:

AT&T:  WSJ pC10 "AT&T should be phoning home" by Miriam Gottfired, WSJ pB4 "AT&T Interest may wane in doing a wireless deal in Europe"  say AT&T is saying its window of opportunity for buying a European asset may be closing.  AT&T is trading at 5.6 estimated '14 earnings while Verizon is at 6.4.

American Express:  No mentions found.

Boeing: IBD pA2  "Boeing inks SpceJet 737 deal" says the Indian budget airline ordered 42 Boeing 737 Max jets with a list price of $4.4 bil.  Boeing's Malaysia Air 777 was 12 years old and had completed more than 7,500 flight cycles.

Caterpillar:  No mentions found.

Chevron:  No mentions found.

Cisco:  No mentions found.

Coke:  IBD pB9 "Dr Pepper aims for less sugar" by Nancy Gondo says Coca Cola is testing a blend for a proprietary sugar Stevia blend to use in some of its drinks while Pepsi is using Sweetmyx as early as this year after FDA approved the Senomyx developed sweetener enhancer.

Disney:  No mentions found.

DuPont:  No mentions found.

Exxon:  No mentions found.

GE:  No mentions found.

Goldman Sachs:   FT p13 "Goldman fraudster Fabulous Fab hit with $825,000 penalty" by Kara Scannell, WSJ pC1 "Bankers hit stock award jackpot" by Justin Baer, Julie Steinberg say execs at Goldman Sachs and JPMorgan as well as 3 other banks examined by the Wall St. Journal reaped big bonuses by cahsing in restricted shares from past years as they vest.

WSJ pC3 "Trader Tourre gets $825,000 penalty" by Ben Fox Rubin says the ex Goldman trader was ordered to pay this after a fed jury last year found him liable of defrauding investor.

FT p21 "Rite Aid advances as Goldman forecasts improved sales growth" by Eric Platt says overall US equity markets drifted lower.  Goldman Sachs research lifted its rating on Rite Aid to buy.

Home Depot:  No mentions found.

Intel:  WSJ pB6 "Chip makers hit pause on tech leap" by Don Clark says the shift to fabricating chips on larger silicon wafers may be slowing as Intel and IBM take a second look.

IBM:   WSJ pB6 "Chip makers hit pause on tech leap" by Don Clark says the shift to fabricating chips on larger silicon wafers may be slowing as Intel and IBM take a second look.

JPMorgan:  WSJ pC1 "Bankers hit stock award jackpot" by Justin Baer, Julie Steinberg says execs at Goldman Sachs and JPMorgan as well as 3 other banks examined by the Wall St. Journal reaped big bonuses by cahsing in restricted shares from past years as they vest.

FT p14 "Blue Buffalo hires JPM to lead $2bn IPO" by Ed Hammond, Arash Massoudi says the luxury US dog food issuer is expected to be value at more than $2bn.

Johnson & Johnson:  No mentions found.

McDonald's:  No mentions found.

Merck:  No mentions found.

Microsoft:  WSJ pB6 "Windows XP in utilities could disrupt security" by Rachael King says Microsoft ending support for its Windows XP op system next month could cause problems for utilities and others.

WSJ pB7 "Microsoft ends Xbox contract plans" by Ian Sherr, Shira Ovide says Microsoft has stopped selling its last generation video game machines at a lower price with a monthly service contract, a model borrowed from the cellphone industry.

Nike:  No mentions found.

Pfizer:  WSJ pB3 "Pfizer to appeal ruling on Celebrex" by Anna Prior, Everdeen Mason, IBD pA2 "In brief" say Pfizer said a fed court has invalidated a patent that would have offered an additional 18 months of US exclusivity and monopoly sales for its blockbuster painkiller Celebrex.

Procter & Gamble:  No mentions found.

3M:  No mentions found.

Travelers:  No mentions found.

United Technologies:  No mentions found.

UnitedHealth Group:  No mentions found.

Verizon:   WSJ pC10 "AT&T should be phoning home" by Miriam Gottfired says AT&T is saying its window of opportunity for buying a European asset may be closing.  AT&T is trading at 5.6 estimated '14 earnings while Verizon is at 6.4.

Visa:  No mentions found.

Walmart:  No mentions found.

Wednesday's Closing Dow Numbers:

Symbol Last Sale Change % Change  Share Volume  Market

T$32.380.15 ▲0.47%24,663,736NYSE
AXP$92.90.30 ▼0.32%2,457,789NYSE
BA$124.431.24 ▼0.99%4,994,193NYSE
CAT$96.820.02 ▼0.02%3,797,127NYSE
CVX$115.651.14 ▲1%6,683,559NYSE
CSCO$21.820.21 ▲0.97%31,747,955NASDAQ-GS
KO$38.470.33 ▼0.85%15,429,091NYSE
DIS$81.380.33 ▲0.41%6,288,896NYSE
DD$66.430.42 ▲0.64%5,540,719NYSE
XOM$94.210.20 ▲0.21%9,486,479NYSE
GE$25.750.15 ▼0.58%20,287,697NYSE
HD$80.560.73 ▼0.9%6,979,061NYSE
INTC$24.760.03 ▲0.12%21,091,805NASDAQ-GS
IBM$186.220.54 ▼0.29%4,770,683NYSE
JPM$57.920.27 ▼0.46%17,834,399NYSE
JNJ$93.60.11 ▲0.12%6,002,493NYSE
MCD$98.710.07 ▼0.07%6,634,370NYSE
MRK$56.810.12 ▲0.21%9,323,515NYSE
MSFT$38.270.25 ▲0.66%30,338,737NASDAQ-GS
NKE$78.970.17 ▲0.22%2,077,266NYSE
PFE$31.980.44 ▼1.36%32,135,035NYSE
PG$79.240.29 ▲0.37%7,312,448NYSE
MMM$132.540.03 ▲0.02%2,455,169NYSE
TRV$83.430.15 ▼0.18%1,725,445NYSE
UTX$115.810.17 ▲0.15%3,134,054NYSE
UNH$77.60.18 ▼0.23%2,819,341NYSE
VZ$46.360.34 ▼0.73%44,587,753DualListedV$226.11.08 ▼0.48%2,335,008NYSE
WMT$75.520.60 ▲0.8%8,199,242NYSE

******************

Here are the current CEOs of the Dow 30 Companies:

AT&T T Randall L. Stephenson (Dallas, TX)


American Express AXP Kenneth I. Chenault (NY, NY)


Boeing BA W. James McNerney, Jr. (Chicago, Ill)


Caterpillar CAT Douglas Oberhelman (Peoria, Ill.)


Chevron CVX John Watson (San Ramon, CA)


Cisco CSCO John Chambers (San Jose, CA)


Coca Cola KO Muhtar Kent (Atlanta, GA)


Disney DIS Robert Iger (Burbank, CA)


DuPont DD Ellen Kullman (Wilmington, DE)


ExxonMobil XOM Rex W. Tillerson (Irving, Tx)


GE Jeffrey R. Immelt (Fairfield, CT)


Goldman Sachs GS Lloyd Blankfein (NY, NY)


Home Depot HD Frank Blake (Atlanta, GA)


Intel INTC Brian Krzanich (Santa Clara, CA)


IBM Virginia M. Rometty (Armonk, NY)


JPMorgan Chase JPM Jamie Dimon (NY, NY)


Johnson & Johnson JNJ Alex Gorsky (New Brunswick, NJ)


McDonald's MCD Donald Thompson (Oak Brook, Ill)


Merck MRK Kenneth Frazier (Whitehouse Station, N.J.)


Microsoft MSFT Steve Ballmer (Redmond, WA) (to be succeeded by Satya Nadella)


Nike NK Mark Parker (Beaverton, OR)


Pfizer PFE Ian Read (NY, NY)


Procter & Gamble PG A. G. Lafley (Cincinnati, OH)


3M MMM Inge Thulin (St. Paul, MN)


Travelers TRV Jay S. Fishman (NY, NY)


UnitedHealthUNC Stephen Hemsley (Minnetonka, MN)


United Technologies UTX Louis Chenevert (Hartford, CT)


Verizon VZ Lowell McAdam (NY, NY)


Visa V Charles W. Scharf (Foster City, CA)


Wal-Mart WMT Mike Duke (to be replaced on Feb. 2014 by Doug McMillon) (Bentonville, ARK)


***************************
Here are the Dow Jones Industrial Average 30 as of 1/27/14 ranked in order of market capitalization in billions:

1. Exxon Mobil XOM $414.66
2. Microsoft MSFT 299.08
3. WalMart WMT 260.40
4. Johnson & Johnson JNJ 253.76
5. GE 253.64
6. Chevron CVX 239.93
7. JPMorgan Chase JPM 221.96
8. Procter & Gamble PG 213.30
9. IBM 193.17
10. Pfizer PFE 192.23
11. AT&T T 176.53
12. Coke KO 171.03
13. Merck MRK 153.49
14. Visa V 137.68
15.  Verizon VZ 136.48
16. Disney DIS 126.96
17. Intel INTC 122.88
18. Cisco CSCO 117.63
19. Home Depot HD 111.17
20.United Technologies UTX 104.41
21. Boeing BA 103.22
22. McDonald's MCD 93.60
23. American Express AXP 92.06
24. 3M MMM 86.82
25. Goldman Sachs GS 75.51
26. UnitedHealth UNH 72.13
27.Nike NKE 63.67
28. Caterpillar CAT 58.09
29. DuPont DD 55.79
30. Travelers TRV 29.9632.20


****************************************
Here are the latest 8K, 10Q & 10K & Proxy & certain other SEC filings as of 1/27/14:

Symbol & Co. Name/Date of Filing/Form Filed/ Comments

AT&T T:
 1/22/14 8K re: certain fin'l items for 4Q
12.18/13 8K re: sale of AT&T's incumbent local exchange opers in Ct. to Frontier Comm. for $ 2 bil
12/16/13 8K re: redemption of shares of Perpetual Cumulative Pref. Stock held by subsidiaries
12/12/13 8K re: amendments to '11 Incentive Plan re: triggers of benefit acclerations
12/11/13 8K re: amendment to $5 bil credit agreement
12/6/13 8K; 11/20/13 8K; 11/14/13 8K & 11/5/13 all re: the tender offer of $3.3 bil of Notes
11/27/13 8K re: sale of $1.6 bil of 2.37% Global Notes due '18
11/25/13 8K re: sale of $1.0 bil of 3.82% Global Notes due '20
11/13/13 8K re: sale of $2 bil Euros of Global Notes
11/1/13 10Q & 2 8Ks 10/23/13 re: results of 3Qtr ended 9/30/13


American Express AXP:
1/16/13 8K re: 4Q results
1/15/14 8K re: deling. & write-off states for 3 mos. through 12/31/13
12/24/13 8K re: settlement with bank regulators re: credit card add-on products
12/19/13 8K re: settlement of class action filed by US merchants
12/16/13 8K re: deling. & write-off states for 3 mos. through 11/30/13
 11/15/13 8K re: delinq. & write-off stats for each of the 3 months ended 10/31/13


Boeing BA:
12/19/13 8K re: promotion of Dennis A. Muilenberg from CEO of Boeing Defense, Space & Security to COO of Boeing & promotion of Raymond L. Conner to Boeing Vice-Chair & CEO of Beoing Comm'l Airplanes & technical amendments to By-laws
12/16/13 8K re: increase in quarterly dividend and add'l $10 bil for stock repurchase program
10/31/13 8K re: $2.3 bil 364 day evolving credit agreement and a $2.3 bil 5 year revolving credit agreement
10/23/13 10Q & 10/23/13 8K re: 3 Qtr ended 9/30/13

Caterpillar CAT:
1/27/14 8K re: 4Q results 12/31/13
1/24/14 8K re: 3 mo. dealer stats thru 12/13
12/23/13 8K re: restructuring of Gosseliers, Belgium ops
12/19/13 8K re: 3 mo. dealer stats thru 11/13
12/11 8K re: mandatory retirement of David R. Goode, Charles D. Powell & amp; amp; amp; amp; amp; Joshua I. Smith from Board & amendment to by-laws
 11/20/13 8K re: supplemental info re: retail sales of machines & power systems
11/1/13 10Q & 10/23/13 2 8Ks re: quarter ended 9/30/13
10/22/13 8K re: retail sales of machinery
10/9/13 8K re: amendment to bylaws re: majority voting for uncontested election of directors


Chevron CVX:
 1/9/14 8K re: interim update for 4Q
12/13/13 8K re: election of Jon M. Huntsman, Jr. to Board & amendment to By-laws
 11/8/13 10Q & 11/1/13 8K re: 3 Qtr ended 9/30/13
10/9/13 8K re: interim update for 3Q

Cisco CSCO:
12/23/13 8K re: exec pre-arranged stock trading plans
12/4/13 8K re: pre-arranged stock trading plan for EVP & Chief Dev. Officer
11/22/13 10Q re: 1 Qtr ended 10/26/13
11/20/13 8K re: amendment of '05 Stock Incentive Plan
11/13/13 8K re: 1 Qtr results & $15 bil increase in share buyback program


Coke KO:
1/24/14 8K & 12/18/13 8K both re: departure of EVP & Pres. of Coca-Cola Americas Steven A. Cahillane
 11/1/13 8K re: completion of public offering of $3.25 bil of notes
10/24/13 8K & 10/24/13 10Q re: qtr ended 9/27/13 & transfer of India & South West Asia units from Eurasia & Africa operating segment to Pacific operating segment
10/15/13 8K re: 3Q results


Disney DIS:
1/24/14 Def. Proxy (& Prelim 12/23/13) re: Annual Shareholders Mtg on 3/18/14 at 10 am Keller Aud., Portland, OR
12/23/13 8K re: election of Jack Dorsey to Board
12/9/13 8K re: Medium-Term Note Program
 11/20/13 & 11/7/13 8K re: fiscal year ended 9/28/13
10/8/13 8K re: amendment to bylaws to eliminate paper share certificates
10/2/13 8K re: new employment contract for Alan N. Braverman EVP, GC & Sec'y for annual salary of $1.4 mil


DuPont DD:
11/6/13 8K and 10/25/13 8K re: separation of Performance Chemicals segment
10/22/13 10Q & 10/22/13 8K re: 3 Qtr ended 9/30/13
10/22/13 & 8K re: results for qtr ended 9/30/13

ExxonMobil XOM:
11/5/13 10Q & 10/31/13 8K re: 3 Qtr ended 9/30/13

GE:
 1/17/14 8K re: 4Q results
11/15/13 8K re: IPO of 20% of N. American Retail Finance business
11/1/13 10Q re 3 Qtr ended 9/30/13
10/18/13 8K re: 3Qtr results
10/16/13 8K re: exercise by Berkshire Hathaway of warrants for 10.7 mil shares


Goldman Sachs GS:
1/16/14 8K re: 4Q & year end results for 12/31/13.
 12/2/13 8K re: approval by regulators of '13 Capital Plan
11/29/13 8K re: $1 bil Flaoting Rate Notes due '23
11/15/13 8K re: $1 bil Floating rate Notes due '18
11/15/13 8K re: Moody's downgrade of Goldman debt
11/7/13 10Q for qtr ended 9/30/13
10/21/13 8K re: retirement of J. Michael Evans as Vice Chair/Head of Growth Markets
10/17/13 8K re: 3Q results
10/1/13 8K re: exercise by Berkshire Hathaway of warrants for 13,062,594 shares


Home Depot HD:
 11/27/13 10Q & 11/19/13 8K re: quarter ended 11/3/13
9/20/13 8K re: election of Helena B. Boulkes to Board of Dirs.
9/10/13 8K re: closing of sale of $3.25 bil notes


Intel INTC:
 1/16/14 8K re: results for 4Qtr & fiscal year ended 12/28/13
12/9/13 8K re: amdmt to '07 Annul Pref. Cash Bonus Plan for Exec Officers
11/22/13 8K re: Investor Meeting
10/28/13 10Q re: Qtr ended 9/28/13
10/23/13 8K re: departure of David Perlmutter, EVP & GM, Architecture Group
10/15/13 2 8Ks re: results for qtr ended 9/28/13



IBM:
1/23/14 8K re: sale of x86 server portfolio to Lenovo
1/22/14 8K re: 4Q earnibgs presentation
1/21/14 8K re: fin'l results for period ending 12/31/13
12/13/13 8K re: consulting contract with retiring Mark Loughridge, SVP
11/20/13 8K re: 750 mil Euro issuance of debt securities
11/7/13 8K re: retirement of Mark Laughridge, SVP & CFO, Finance & Enterprise Transformat'n
11/6/13 8K re: 2.5 bil Euro sale of debt securities
11/1/13 8K recommendation against mini-tender offer by third parties

JPMorganChase JPM:
1/24/14 8K re: grant of restricted stock units to CEO Jamie Dimon
1/22/14 8K re: issuance of fixed to floating rate non-cumulative preferred stock
1/14/14 2 8Ks re: 4Q results
1/7/14 8K re: settlement with various regulations relating to Madoff fraud
1/3/14 8K re: election of Michael A. Nead to Board
11/20/13 8K re: settlement by payment of $13 bil to settle with the President's Residential Mortgage Backed Securities (RMBS) Work Group of the Fin'l Fraud Enforcement Task Force
11/18/13 8K re: settlement by payment of $4.5 bil with 21 inst'l investors re: RMBS claims
11/1/13 10Q for quarter ended 9/30/13

Johnson & Johnson JNJ:
1/21/14 8K re: 4Q 7 fiscal year ended 12/29/13 results
1/17/14 8K re: sale to Carlyle Group of Ortho-Clinical Diagnostics unit
12/4/13 8K re: sale of $3.5 bil Floating Rate notes
11/19/13 8K re: settlement of $2.5 Bil for DePuy hip system claims
11/4/13 10Q for Qtr ended 9/29/13


McDonald's MCD:
 1/23/14 8K re: 4Q & full year results for period ended 12/31/13
12/9/13 8K re: Nov. sales
11/14/13 8K re: sale of 3 mil shares of Ckommon Stock
11/14/13 8K re: Investor Release re: future growth
11/8/13 8K re: 10/13 sales
10/30/13 10Q for Qtr ended 9/30/13
10/21/13 8K re: 3Q results


Merck MRK:
11/7/13 10Q & 10/28/13 8K re: 3 Qtr ended 9/30/13
10/1/13 8K re: global restructuring program and lay-offs of 8,500 employees


Microsoft MSFT:
1/23/14 10Q & 1/23/14 8K re: 4Q ended 12/31/13
12/6/13 8K re: issuance ofover $5 bil of notes un Euros & US Dollars
11/26/13 8K re: restructuring to a devices & services company
11/20/13 8K re: voting results of '13 Annual Meeting of Sahreholders on 11/19/13
10/24/13 10Q & 10/24/13 8K re: Qtr ended 9/30/13
10/8/13; 10/7/13 & 10/3/13 Proxy Materials re: annual shareholders meeting on 11/19 in Bellevue, Washington


Nike NKE:
1/7/1410Q  & 12/23/14 8K & 12/19/13 8K re: 4Q ended 11/30/13
10/7/13 10Q, 9/30/13 8K & 9/26/13 8K re: results for qtr ended 8/31/13
9/24/13 8K re: voting results of annual meeting of shareholders on 9/19/13


Pfizer PFE:
12/28/13 8K re: retirement of M. Anthony Burns from Board
12/19/13 8K re: amdmt of By-laws
12/17/13 8K re: promotion of Albert Bourla to Group VP, Vaccine, ONcology & amp; amp; amp; amp; amp; Consumer Health instead of Amy Schulman who leaves Pfizer (she was GC) & promotion of Susan Silberman to Pres. & amp; GM Global Vaccines
11/8/13 10Q & 10/29/13 8K re: 3 Qtr ended 9/29/13


Procter & Gamble PG:
1/24/14 10Q & 1/24/14 2 8Ks re: results for fiscal year ended 12/31/13
1/14/14 8K re: declaration of quarterly dividend
12/13/13 8K re: amdmt to Code of Regulations
11/5/13 8K re: close of sale of 750 mil Euros 2% Notes due '21
11/4/13 8K close of sale of $2 bil Notes
10/28/13 8K re: reorganizing of Global Business Unit into: Global Beauty, Global Health & Grooming, Blogal Fabric & Home Care, & amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; amp; Global Baby, Feminine & amp; amp; Family Unit
10/25/13 10Q & 2 8Ks re: 1 Qtr ended 9/30/13
10/11/13 8K re: voting results of annual shareholders meeting 10/8/13
10/8/13 8K re: declaration of quarterly dividends


3M MMM:
12/17/13 8K re: declaration of dividend & update of its 5 year plan ('13 - '17)
11/19/13 3 8Ks re: pre-arranged stock trading plans for CEO and other execs
10/31/13 10Q & 10/24/13 8K re: 3 Qtr ended 10/24/13


Travelers TRV:
1/21/14 8K re: 4Q results ended 12/31/13
10/22/13 10Q & 10/22/13 8K re: results for qtr ended 9/30/13


United Technologies UTX:
1/22/14 8K re: 4Q results
12/13/13 8K re: amdmt to B-Laws re: forum to adjudicate certain disputes
10/25/13 10Q & 10/22/13 8K re: 3 Qtr ended 9/30/13
10/22/13 8K re: 3Q results


UnitedHealth Group UNH:
 1/16/14 8K re: 4Q & full year results
1/3/14 8K re: presentation at Goldman Scahs Healthcare Conf.
12/2/13 8K re: Annual Investors Conference to be held 12/3 in NYC
11/7/13 10Q re: 3 Qtr ended 9/30/13
10/17/13 8K re: 3Q results

Verizon Communications Inc. VZ:
1/21/14 8K re: 4Q results
12/10/13 8K re: issuance of shares to purchase Vodafone's 45% interest in Verizon Wireless
12/10/13 Proxy re: Special Mtg of Shareholders re: Vodafone  1/28/14 10 am Westin Governor Morris, Morristown, NJ
11/7/13 8K re: election of Shellye Archambeau as Dir.
10/24/13 10Q for Qtr ended 9/30/13
10/17/13 8K re: 3Q results
10/8/13 Proxy; 10/8/13 S-8 & 10/3/13 8K re: approval by shareholders to buy Vodafone's 45% interest in Verizon Wireless, registration of shares to be issued to Vodafone, & $12 bil credit facility to fund the purchase


Visa V:
 12/13/13 Proxy re: Annual Mtg of Stockhodlers 1/29/14 8:30 am Crowne Plaza, Foster City, CA
11/25/13 8K re: Gary P. Coughlan not running for re-election to Board
11/22/13 10 K & 10/30/13 8K re: FY 9/30/13
10/23/13 8K re: '14 Annual Meeting of Shareholders to be held 1/29/14

WalMart WMT:
 12/10/13 8K re: promotion of David Cheesewright to Pres. & CEO Walmart Int'l
12/6/13 10Q & 11/14/13 8K re: 3 Qtr ended 10/31/13
11/28/13 8K re: repalcement of CEO Mike Duke with C. Douglas McMillon effective 2/1/13
11/22/13 8K re: election of Pamela C. Craig to Board
10/21/13 10Q for quarter ended 7/31/13
10/1/13 8K re: issuance of 1.95% Notes due 2018

THAT'S All.